日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Sinonasal Sarcomas Management: An International Consensus Statement

鼻窦肉瘤的治疗:国际共识声明

Vinciguerra, Alessandro; Caspani, Francesca; Valentini, Marco; Camarda, Anna Maria; Provenzano, Salvatore; Wang, Eric W; Meço, Cem; Ferrari, Marco; Surda, Pavol; Harrabi, Semi; Campos, Fernando Augusto Batista; Broto, Javier Martin; Guadagnolo, B Ashleigh; Navarria, Pierina; Hosni, Ali; Hindi, Nadia; Italiano, Antoine; Trifiletti, Daniel M; Kasper, Bernd; Verillaud, Benjamin; Schreiber, Alberto; Castelnuovo, Paolo; Nicolai, Piero; Dallan, Iacopo; Chacon, Matias; Su, Shirley Y; Thariat, Juliette; Valverde, Claudia; Lechner, Matt; Blay, Jean Yves; Fiore, Maria Rosaria; Eloy, Jean Anderson; Brahmi, Mehdi; Palmer, James N; Oliden, Victor Castro; Greto, Daniela; Lugowska, Iwona; Tos, Angelo Paolo Dei; van Zele, Thibaut; Psaltis, Alkis J; Casali, Paolo Giovanni; Dufresne, Armelle; Sangalli, Claudia; Georgalas, Christos; Orlandi, Ester; Wormald, Peter-John; Herman, Philippe; Carrau, Ricardo; Hanna, Ehab Y; Licitra, Lisa; Turri-Zanoni, Mario; Battaglia, Paolo

Histopathological Response After Neoadjuvant Chemotherapy for High-Risk Soft-Tissue Sarcomas: A Secondary Analysis of a Randomized Clinical Trial

高危软组织肉瘤新辅助化疗后的组织病理学反应:一项随机临床试验的二次分析

Pasquali, Sandro; Collini, Paola; Romagosa, Cleofe; Coindre, Jean-Michel; Pizzamiglio, Sara; Verderio, Paolo; Duroni, Valeria; Barisella, Marta; Palmerini, Emanuela; Quagliuolo, Vittorio; Martin Broto, Javier; Pousa, Antonio Lopez; Grignani, Giovanni; Brunello, Antonella; Blay, Jean-Yves; Lugowska, Iwona; Fontana, Valeria; Bianchi, Giuseppe; Palassini, Elena; Renne, Salvatore Lorenzo; Casali, Paolo Giovanni; Miceli, Rosalba; Sbaraglia, Marta; Gambarotti, Marco; Bagué, Silvia; Dei Tos, Angelo Paolo; Stacchiotti, Silvia; Gronchi, Alessandro

Development of a Health-Related Quality of Life Tool for Adolescents and Young Adults With Cancer

为患有癌症的青少年和青年开发健康相关生活质量评估工具

Sodergren, Samantha Claire; Husson, Olga; Janssen, Silvie; Rohde, Gudrun Elin; Hossain, M Jamal; Abaza, Haneen; Alkan, Ali; Al-Omari, Amal; Ben-Aharon, Irit; Bentsen, Line; Guren, Marianne G; Ioannidis, Georgios; Ishiki, Hiroto; Koehler, Michael; Lidington, Emma; Lugowska, Iwona; McDonald, Fiona; Krishnamurthy, Manjunath Nookala; Korenblum, Chana; Majorana, Alessandra; Memos, Nikolaos; Otth, Maria; Pappot, Helle; Pérez-Campdepadrós, Marta; Petranovic, Duska; Richter, Diana; Roganovic, Jelena; Scheinemann, Katrin; Sikora-Koperska, Anna; Stark, Dan; Stavrou, Niki; Turhal, Serdar; Winterling, Jeanette; Yarom, Noam; Darlington, Anne-Sophie Emma

Redefining radiologic responses in high-risk soft-tissue sarcomas treated with neoadjuvant chemotherapy: final results of ISG-STS 1001, a randomized clinical trial

重新定义接受新辅助化疗的高危软组织肉瘤的放射学反应:ISG-STS 1001 随机临床试验的最终结果

Vanzulli, A; Vigorito, R; Buonomenna, C; Palmerini, E; Quagliuolo, V; Broto, J M; Lopez Pousa, A; Grignani, G; Brunello, A; Blay, J-Y; Diaz Beveridge, R; Ferraresi, V; Lugowska, I; Pizzamiglio, S; Verderio, P; Duroni, V; Fontana, V; Donati, D M; Palassini, E; Bianchi, G; Bertuzzi, A; Buonadonna, A; Pasquali, S; Dei Tos, A P; Casali, P G; Morosi, C; Stacchiotti, S; Gronchi, A

A Novel B7-H4xCD3 Bispecific T-cell Engager (PF-07260437) Synergizes with Breast Cancer Standard of Care and Immune Checkpoint Therapies

一种新型B7-H4xCD3双特异性T细胞衔接器(PF-07260437)与乳腺癌标准疗法和免疫检查点疗法具有协同作用

Keith Abayasiriwardana # ,Lei Wu # ,Hanane Laklai # ,Malgorzata Nocula-Lugowska ,Lioudmila Tchistiakova ,Jatin Narula ,Amy Jackson-Fisher ,Jonathon Golas ,My-Hanh Lam ,Veronika Grinstein ,Jung Wook Kang ,Jessica C Kearney ,Christine Hosselet ,Erik Upeslacis ,LuAnna Lemon ,Yun Zhang ,Changhua Ji ,Bernard S Buetow ,Martin B Finkelstein ,Netonia Marshall ,Stephanie Bisulco ,Edward Rosfjord ,Divya Mathur ,Jennifer Athanacio ,Ashley Thomas ,Alexander Trageser ,Diane Fernandez ,Ziyue Karen Jiang ,Sripad Ram ,Edward Cabral ,Lisa Manzuk ,Kevin Maresca ,Anand Giddabasappa ,Clare Lees ,Andrea T Hooper ,Puja Sapra ,Sudhakar Chintharlapalli

Ligand non-competitive GITR antibody prevents formation of the obligatory signal-triggering GITRL: GITR stoichiometry

配体非竞争性GITR抗体可阻止必需的信号触发复合物GITRL:GITR的形成

Yan, Jing; Min-DeBartolo, Jessica; Huang, Ching-Shin; Sharif, M Nusrat; Li, Li; Fish, Susan; Dower, Corey; Murphy, Denise; Andreyeva, Tatyana; Liu, Heng; Han, Xinbing; Zheng, Wei; Ooi, Jot Hui; Edmonds, Jason; Chen, Ting; Maben, Zachary; Stevens, Chad R; Goihberg, Polina; Nocula-Lugowska, Malgorzata; Evans, Steven M; Mosyak, Lidia; Kelleher, Kerry; Dickinson, Caitlyn; Hegen, Martin; Winkler, Aaron; Karlsson, Fridrik

A phase I, open-label, multicentre, first-in-human study to evaluate safety, pharmacokinetics and efficacy of AMG 404, a PD-1 inhibitor, in patients with advanced solid tumours

一项 I 期、开放标签、多中心、首次人体试验,旨在评估 PD-1 抑制剂 AMG 404 在晚期实体瘤患者中的安全性、药代动力学和疗效。

Price, Timothy; Lugowska, Iwona; Chawla, Sant P; Falchook, Gerald; Subbiah, Vivek; Monzon, Jose G; Arkenau, Hendrik-Tobias; Hui, Mun; Kuboki, Yasutoshi; Dziadziuszko, Rafal; Shibaki, Ryota; Hong, Min Hee; Tan, Daniel; Rocha Lima, Caio Max; Wang, Kejia; Hindoyan, Antreas; Shi, Weibing; Wong, Hansen; Kistler, Mira; Prenen, Hans

A First-In-Human Study of the SUMOylation Inhibitor Subasumstat in Patients with Advanced/Metastatic Solid Tumors or Relapsed/Refractory Hematologic Malignancies

一项针对晚期/转移性实体瘤或复发/难治性血液系统恶性肿瘤患者的SUMO化抑制剂Subasumstat的首次人体研究

Dejan Juric ,Daniel Anderson ,Afshin Dowlati ,Jordi Rodon ,Iwona Lugowska ,Sławomir Mańdziuk ,Yuqin Song ,Feng Jung Sherida H Woei-A-Jin ,Marc André ,Joanna Góra Tybor ,José-Ángel Hernández-Rivas ,Razelle Kurzrock ,Armando López-Guillermo ,David Schröder ,Rafal Stec ,Allison Berger ,Bo Chao ,Aleksander Chudnovsky ,John P Gibbs ,Tao Long ,Dina Stroopinsky ,Qi Dong ,Anthony J Olszanski

Phase 2 study of the antitumour activity and safety of simlukafusp alfa (FAP-IL2v) combined with atezolizumab in patients with recurrent and/or metastatic cervical squamous cell carcinoma

一项评估simlukafusp alfa (FAP-IL2v)联合atezolizumab治疗复发性和/或转移性宫颈鳞状细胞癌患者的抗肿瘤活性和安全性的II期研究

Verlingue, Loic; Italiano, Antoine; Prenen, Hans; Guerra Alia, Eva Maria; Tosi, Diego; Perets, Ruth; Lugowska, Iwona; Moiseyenko, Vladimir; Gumus, Mahmut; Arslan, Cagatay; Lindsay, Colin R; Deva, Sanjeev; Taus, Álvaro; Oaknin, Ana; Rottey, Sylvie; Cicin, Irfan; Goksu, Sema Sezgin; Smolin, Alexey; Roselló-Keränen, Susana; Habigt, Christin; Marbach, Daniel; Boetsch, Christophe; Dejardin, David; Sleiman, Nassim; Evers, Stefan; Richard, Muriel; Ardeshir, Caroline; Charo, Jehad; Kraxner, Anton; Teichgräber, Volker; Keshelava, Nino; Dziadziuszko, Rafal

Randomized, open-label, phase 2 study of nivolumab plus ipilimumab or nivolumab monotherapy in patients with advanced or metastatic solid tumors of high tumor mutational burden

一项随机、开放标签的 II 期研究,旨在评估纳武利尤单抗联合伊匹木单抗或纳武利尤单抗单药治疗高肿瘤突变负荷的晚期或转移性实体瘤患者的疗效。

Schenker, Michael; Burotto, Mauricio; Richardet, Martin; Ciuleanu, Tudor-Eliade; Gonçalves, Anthony; Steeghs, Neeltje; Schoffski, Patrick; Ascierto, Paolo A; Maio, Michele; Lugowska, Iwona; Lupinacci, Lorena; Leary, Alexandra; Delord, Jean-Pierre; Grasselli, Julieta; Tan, David S P; Friedmann, Jennifer; Vuky, Jacqueline; Tschaika, Marina; Konduru, Somasekhar; Vemula, Sai Vikram; Slepetis, Ruta; Kollia, Georgia; Pacius, Misena; Duong, Quyen; Huang, Ning; Doshi, Parul; Baden, Jonathan; Di Nicola, Massimo